Skip to main content
. 2020 Jul 6;112(6):4189–4202. doi: 10.1016/j.ygeno.2020.07.003

Table 2.

Nucleotide modifications distribution along the SARS-COV 2 genome comparing to the Cov-RATG13 genome.

Region Begin End Length Protein Nucleotide modification RATG13
Nucleotide modification Pangolin
Number (%) Number (%)
1 5′UTR 16 265 250 6 (2.4%) 2 (0.8%)
2 Gene = “orf1ab” 266 21,555 21,290 GU280_gp01 744 (3.494%) 1924 (9%)
3 Gene = “S” 21,563 25,384 3822 GU280_gp02 271 (7.09%) 323 (8.45%)
4 Gene = “ORF3a” 25,393 26,220 828 GU280_gp03 31 (3.743%) 34 (4.106%)
5 Gene = “E” 26,245 26,472 228 GU280_gp04 1 (0.438%) 2 (0.877%)
6 Gene = “M” 26,532 27,191 660 GU280_gp05 30 (4.545%) 38 (5.75%)
7 Gene = “ORF6” 27,202 27,387 186 GU280_gp06 3 (1.612%) 3 (1.61%)
8 Gene = “ORF7a” 27,394 27,759 366 GU280_gp07 16 (4.371%) 24 (6.557%)
9 Gene = “ORF7b” 27,756 27,887 132 GU280_gp08 1 (0.757%) 132 (100%)
10 Gene = “ORF8” 27,894 28,259 366 GU280_gp09 11 (3.005%) 229 (62.5%)
11 Gene = “N” 28,274 29,533 1260 GU280_gp10 39 (3095%) 48 (3.809%)
12 Gene = “ORF10” 29,558 29,674 117 GU280_gp11 1 (0,854%) 1 (0.854%)
13 3′UTR 29,675 29,889 229 3 (1.39%) 0 (0%)